Researchers report a targeted therapy that blocks LSD1 effectively shrinks tumor size in mouse models of medulloblastoma, a form of pediatric brain cancer.
Researchers report improved survival rates in people who received chemotherapy postoperatively for medulloblastoma brain cancer.
